Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.4B | 1.5B | 1.5B | 1.6B |
Cost of revenue | 1.2B | 1.3B | 1.3B | 1.3B |
Gross profit | 201M | 188M | 234M | 243M |
Operating expense | ||||
Research & development | 32M | 30M | 27M | 33M |
Selling general and admin | 166M | 166M | 153M | 176M |
Other operating expenses | -7M | 48M | 7M | -5M |
Operating income | 10M | -56M | 47M | 39M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 19M | 19M | 21M | 20M |
Other income expense | 36M | -6M | 8M | 25M |
Pretax income | 27M | -81M | 34M | 44M |
Tax provision | 15M | 29M | 39M | 13M |
Net income | 11M | -125M | -17M | 38M |
Basic EPS | 0.0 | -0.8 | -0.2 | 0.1 |
Diluted EPS | 0.0 | -0.8 | -0.2 | 0.1 |
Basic average shares | 192.0M | 192.0M | 192.0M | 192.0M |
Diluted average shares | 192.0M | 192.0M | 192.0M | 193.1M |
EBITDA | 83M | 71M | 130M | 143M |
Net income from continuing op. | 12M | -110M | -5M | 31M |
Minority interests | -16M | -16M | -16M | -16M |
Preferred stock dividends | — | — | — | — |